KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.311 $0.311 Friday, 27th Jan 2023 TYME stock ended at $0.311. During the day the stock fluctuated 0% from a day low at $0.311 to a day high of $0.311.
90 days $0.311 $0.311
52 weeks $0.219 $0.405

Historical Tyme Technologies Inc prices

Date Open High Low Close Volume
Jul 29, 2022 $0.290 $0.300 $0.288 $0.295 230 066
Jul 28, 2022 $0.285 $0.300 $0.285 $0.293 387 741
Jul 27, 2022 $0.290 $0.301 $0.280 $0.292 589 924
Jul 26, 2022 $0.300 $0.303 $0.283 $0.291 660 920
Jul 25, 2022 $0.300 $0.301 $0.288 $0.297 559 007
Jul 22, 2022 $0.300 $0.305 $0.287 $0.301 536 565
Jul 21, 2022 $0.314 $0.322 $0.295 $0.300 634 944
Jul 20, 2022 $0.299 $0.311 $0.295 $0.300 1 516 385
Jul 19, 2022 $0.298 $0.309 $0.295 $0.296 676 593
Jul 18, 2022 $0.300 $0.310 $0.295 $0.297 774 566
Jul 15, 2022 $0.280 $0.304 $0.280 $0.296 2 140 059
Jul 14, 2022 $0.290 $0.294 $0.285 $0.291 1 900 304
Jul 13, 2022 $0.289 $0.300 $0.280 $0.288 926 517
Jul 12, 2022 $0.284 $0.300 $0.280 $0.300 1 027 502
Jul 11, 2022 $0.281 $0.300 $0.281 $0.283 1 330 720
Jul 08, 2022 $0.260 $0.300 $0.260 $0.290 2 078 947
Jul 07, 2022 $0.263 $0.275 $0.256 $0.264 3 930 889
Jul 06, 2022 $0.292 $0.296 $0.261 $0.261 3 625 403
Jul 05, 2022 $0.335 $0.405 $0.287 $0.292 26 125 066
Jul 01, 2022 $0.279 $0.287 $0.260 $0.270 683 730
Jun 30, 2022 $0.267 $0.298 $0.263 $0.280 476 384
Jun 29, 2022 $0.260 $0.298 $0.260 $0.275 1 337 981
Jun 28, 2022 $0.285 $0.285 $0.260 $0.264 384 551
Jun 27, 2022 $0.273 $0.286 $0.250 $0.285 462 625
Jun 24, 2022 $0.280 $0.300 $0.243 $0.243 600 410
Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT